Onsite Oral Fluid Drug Testing Device
The most recent Australian Standard for drug testing in oral fluid (AS/NZS 4760:2019) was released in March 2019.
For onsite devices, the major changes to the Australian drug testing standard introduced in 2019 are:
- The cut-off level for THC has been reduced from 25ng/mL to 15ng/mL.
- Oxycodone (40ng/mL) has been added as a separate drug group to be tested for.
ToxWipe 7 – independently verified to 2019 Standard
Safework Labs can provide you with ToxWipe 7 for all your oral fluid onsite drug testing needs. The device has been independently verified to AS/NZS 4760:2019.
The ToxWipe 7 has been investigated for all drugs as per the Australian Standard, including benzodiazepines, and meets all the new standard’s performance criteria.
The ToxWipe 7 was submitted to the Victorian Institute of Forensic Medicine (VIFM) for testing against specificity, sensitivity and compliance to manufacturer performance claims.
The six drugs listed in AS/NZS 4760:2019 plus benzodiazepines were investigated and the ToxWipe 7 was confirmed by VIFM to meet the performance claims.
This means the device is considered “fit for purpose” for onsite oral fluid testing in accordance with AS/NZS 4760:2019.
ToxWipe 7 cut-off concentrations
|Drug Class||Cut-off (ng/ml)|
For companies using SW Labs for in-house drug testing services
We are presently working towards accreditation to Appendix A (onsite testing procedure) of AS/NZS 4760:2019. Once achieved, we will be able to offer you a fully accredited end to end process. This means onsite testing to sample collection, transport and dispatch of non-negative samples to the laboratory for confirmation testing. This will provide you with the highest level of confidence for your business in the case of any Fair Work challenges.
For companies conducting their own in-house drug testing
If you have an in-house drug and alcohol testing program, the ToxWipe 7 is available for you to purchase from us now.
Please contact us for more information or a quote.1300 795 227